FILTRIX Logo FILTRIX Find Your Edge →

Latest signal:

AMGN Stock Analysis

Data source: Trade-Ideas Alerts | 82 alerts analyzed | Backtest period: 2022-01-18 → 2025-02-03

⚠️ Small sample size (82 alerts). Statistics may have high variance. Interpret with caution.

🏢 Company Profile

📍 NASDAQ 📅 IPO: Jun 17, 1983 🔗 www.amgen.com
💰 Market Cap: $185.64B 👥 Employees: 28,000
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
📊
82
Total Alerts
🎯
57.3%
Win Rate (60MIN)
💰
-0.01%
Avg Gain (60MIN)
🚀
+1.16%
Avg MFE (Max Potential)

📈 Performance by Timeframe

5MIN

Win Rate: 51.2%
Avg Gain: +0.03%
Avg Winner: +0.48%
Avg Loser: -0.45%
Best: +1.46%
Worst: -2.16%
Trades: 42/40

15MIN

Win Rate: 50.0%
Avg Gain: +0.02%
Avg Winner: +0.60%
Avg Loser: -0.56%
Best: +1.95%
Worst: -1.99%
Trades: 41/41

30MIN

Win Rate: 54.9%
Avg Gain: -0.01%
Avg Winner: +0.59%
Avg Loser: -0.75%
Best: +2.05%
Worst: -1.91%
Trades: 45/37

60MIN

Win Rate: 57.3%
Avg Gain: -0.01%
Avg Winner: +0.68%
Avg Loser: -0.94%
Best: +2.42%
Worst: -2.86%
Trades: 47/35

EOD (End of Day)

Win Rate: 53.7%
Avg Gain: +0.17%
Avg Winner: +1.24%
Avg Loser: -1.07%
Best: +7.31%
Worst: -5.50%
Trades: 44/38

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +1.16%
Best MFE: +7.43%
Avg Time to MFE: 149 min

On average, AMGN alerts reach +1.16% profit potential within 149 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -0.44%
Worst MAE: -1.87%
Avg Time to MAE: 11 min

Before reaching MFE, expect an average drawdown of 0.44%.

⚖️ Risk/Reward Ratio

2.65:1

Excellent risk/reward - potential gain is 2.65x the typical drawdown.

💡 Trading Insight: Based on 82 alerts, AMGN typically reaches +1.16% profit before pulling back. Consider setting profit targets around 0.9% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 82
Gap Up % 43.9%
Avg Gap +0.04%
Best Gap +1.35%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How AMGN compares to 128 other tickers in the same sector.

5-Min Gain
AMGN: +0.03% Sector: -0.41% +0.44%
EOD Gain
AMGN: +0.17% Sector: +1233.50% -1233.33%
Avg MFE
AMGN: +1.16% Sector: +6.69% -5.53%

📋 Last 20 Alerts

Historical AMGN alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2025-02-03 09:27:25 $286.94 -0.16% -0.06% -1.06% +0.08% +0.67% +0.92% -1.23% -0.01% LOSS
2025-01-27 09:25:27 $277.98 +0.25% +0.81% +0.30% +0.17% +1.79% +1.89% -0.65% -0.22% WIN
2025-01-23 09:25:11 $273.54 -0.18% -0.06% -0.21% -0.11% +1.59% +1.63% -0.45% -0.04% LOSS
2025-01-06 09:26:29 $260.92 -0.58% -0.23% -0.46% -0.31% -0.89% +0.10% -1.04% -0.72% LOSS
2024-12-24 09:25:13 $262.54 +0.12% -0.16% -0.11% +0.40% +0.74% +0.77% -0.45% -0.02% WIN
2024-12-20 09:27:57 $269.02 -2.16% -0.69% -0.19% -1.52% -2.10% +0.55% -0.57% -0.01% LOSS
2024-12-12 09:26:36 $273.01 +0.50% +0.91% +0.42% +0.75% +0.38% +1.05% -0.16% +0.29% WIN
2024-12-11 09:28:53 $274.53 +0.32% +0.37% +0.17% -0.57% -0.41% +0.64% -0.08% +0.54% WIN
2024-12-06 09:26:40 $275.1 -1.12% -0.72% -0.59% -0.78% -0.92% +0.35% - -0.03% LOSS
2024-12-03 09:28:28 $277.52 +0.34% +0.48% +0.71% +0.26% +0.29% +1.39% -0.37% -0.19% WIN
2024-11-27 09:26:18 $277.21 +1.00% +1.48% +0.69% +1.35% +1.03% +1.98% +0.28% +0.65% WIN
2024-11-26 09:25:59 $260.94 +1.46% +0.21% +1.29% -0.86% +7.31% +7.43% -1.20% +1.26% WIN
2024-11-20 09:27:57 $277.35 +1.24% +0.68% +1.05% +1.08% +3.79% +4.01% +0.44% +1.35% WIN
2024-11-13 09:27:17 $308.1 -0.73% -1.29% -1.48% -2.55% -2.16% -0.22% -1.87% -0.68% LOSS
2024-11-11 09:27:50 $325.89 +0.30% +0.29% +0.15% -0.35% -1.25% +0.52% -0.63% +0.01% WIN
2024-09-26 09:25:10 $312.34 +0.81% +0.68% +0.90% +1.48% +2.16% +2.38% +0.12% +0.43% WIN
2024-08-12 09:28:25 $323.61 -0.18% -0.86% -1.25% -1.23% -1.12% +0.09% -0.57% +0.09% LOSS
2024-07-18 09:25:45 $334.51 -0.09% +0.39% +0.68% +0.95% -1.06% +1.34% -0.30% -0.09% LOSS
2024-06-03 09:25:37 $305.94 +0.21% +0.33% +1.31% +1.50% +0.48% +1.81% -0.30% +0.28% WIN
2024-05-10 09:27:20 $313.5 -0.45% -0.40% -0.22% +0.12% -1.07% +0.44% -0.84% -0.19% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

⚠️ AMGN Shows Negative Expectancy

Despite a 57.3% win rate, AMGN has -0.01% average expectancy because losses outweigh wins. Use the app to find filters that improve the win size or reduce loss size, making AMGN profitable.

🔧 Fix AMGN Risk/Reward →

Why Analyze AMGN with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for AMGN. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, AMGN historically offers an average upside of +1.16% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 AMGN Momentum Personality

With a baseline win rate of 57.3%, AMGN shows negative expectancy despite winning more often - average losses (-0.94%) outweigh average wins (+0.68%). This suggests the need for tighter stops or better entry timing.

⏱️ Optimized Exit Timing

⚠️ Caution Advised: AMGN shows negative expectancy across all tested intraday timeframes (Best: 60MIN at -0.01%). This suggests AMGN is prone to fading after the open, making it a potential candidate for short-selling or quick scalps only.